Use of Dexmedetomidine to Discontinue High-Dose Fentanyl

Abstract

Get full access to this article

View all access options for this article.

References

Gerlach

, Dasta

. Dexmedetomidine: an updated review. Ann Pharmacother 2007; 41:245–52. DOI 10.1345/aph.1H314

Honey

, Benefield

, Miller

, Johnson

. α-Receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother 2009; 43:1506–11. DOI 10.1345/aph.1M161

Wallace

, Mecklenburg

, Hanling

. Profound reduction in sedation and analgesic requirements using extended dexmedetomidine infusions in a patient with an open abdomen. Mil Med 2009; 174:1228–30.

Multz

. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg 2003; 96:1054–5. DOI 10.1213/01.ANE.0000050773.70232.08

Finkel

, Johnson

, Quesado

ZMN

. The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children. Crit Care Med 2005; 33:2110–2. DOI 10.1097/01.CCM.0000178183.21883.23

Tobias

. Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU. J Opioid Manag 2006; 2:201–5.

Belgrade

, Hall

. Dexmedetomidine infusion for the management of opioid-induced hyperalgesia. Pain Med 2010; 11:1819–26. DOI 10.1111/j.1526-4637.2010.00973.x